Over exfoliation can irritate the skin, so keep it mild and always moisturise after bath
Currently (February 2024), the EMA is considering the wider use of Wegovy to include reducing cardiovascular events this is critical for coverage in many European health systems, including the largest, Germany, which refuse to cover it for weight loss alone
Contact us or book an appointment today
Obesity 34(4), 770781
Timing of medication administration is particularly important
The documented considerations include mild water retention (a class effect of raising GH), injection-site reactions, occasional headache or lightheadedness, and most importantly for long-term thinking IGF-1 and sustained-GH-elevation considerations, which are why cycling with breaks is favored over indefinite use